Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical studyYuzhong Cui, Baosheng Li, Xiaoyang Yin et al.|Clinical & Translational Oncology|2022Cited by 5
Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical studyYuzhong Cui, Baosheng Li, Feng Du et al.|Clinical & Translational Oncology|2022Cited by 0